The mechanisms, effectiveness and limitation of currently used pharmacological treatments for cancer will be discussed. You will learn how new mechanisms are researched and exploited as future pharmacology targets. Also the rationale for and current status of biological therapies such as gene, antibody and immunological therapy, will be discussed in the context of cancer therapy. The module aims to provide an overview of current areas of interest and controversy in the clinical management of cancer. Surgery or no surgery- that is the question? Cancers from CNS to colorectal will each be discussed together with their current recommended treatment regimes.
Module Attendance Required
2 blocks week of teaching
7 – 11 March 2016
13 – 17 June 2016
MCQ exam plus oral presentations
Academics involved in the delivery of this module
Dr Jean Assender, Lecturer Cancer Studies and Clinical Oncology Programme Lead, and Dr Emilio Porfiri, Senior Lecturer Cancer Studies and NHS Consultant
Stand Alone Course
This module can be taken as a stand alone course if required.
Fee if taken as a stand alone course
This course is available without the assessment/credits if preferred.
For further information please contact:
Tel: +44 (0)121 414 3803